Submit a comment

Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens
F. T. Rapaport, … , H. S. Lawrence, J. M. Converse
F. T. Rapaport, … , H. S. Lawrence, J. M. Converse
Published October 1, 1968
Citation Information: J Clin Invest. 1968;47(10):2206-2216. https://doi.org/10.1172/JCI105906.
View: Text | PDF
Research Article

Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens

Abstract

Erythrocyte group antigens A and B can act as potent and group-specific transplantation antigens in man. ABO group-incompatible recipients pretreated with such antigens have rejected skin allografts obtained from donors incompatible for the same antigens in an accelerated (4-5 days) or white graft manner. Skin grafts applied to the same recipients from ABO-compatible donors were accorded first-set survival times. Intact erythrocyte suspensions and antigens isolated from hog (A substance) and horse (B substance) stomachs, were equally capable of inducing this type of allograft sensitivity. The latter observation broadens the spectrum of heterologous antigens capable of inducing allograft sensitivity in the mammalian host and provides a readily available, heat-stable, and water-soluble source of antigens for further studies of allograft rejection mechanisms in man.

Authors

F. T. Rapaport, J. Dausset, L. Legrand, A. Barge, H. S. Lawrence, J. M. Converse

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required